AAN illustration

Multiple Sclerosis News Today is providing virtual coverage of the 2024 Annual Meeting for the American Academy of Neurology taking place April 13-18 in Denver. Stay tuned to this page for all the latest news.

News

AAN 2024: Subcutaneous Ocrevus led to nearly no relapses after year

A subcutaneous (under-the-skin) formulation of Ocrevus (ocrelizumab) helped most adults with multiple sclerosis (MS) remain free of clinical relapses and new or worsening brain lesions, according to one-year data from the Phase 3 OCARINA II study. Given twice a year as a 10-minute injection, this formulation of Ocrevus…